Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study

被引：0

作者：

R. Velasco

S. Mercadal

N. Vidal

M. Alañá

M. I. Barceló

M. J. Ibáñez-Juliá

S. Bobillo

R. Caldú Agud

E. García Molina

P. Martínez

P. Cacabelos

A. Muntañola

G. García-Catalán

J. M. Sancho

I. Camro

T. Lado

M. E. Erro

L. Gómez-Vicente

A. Salar

A. C. Caballero

M. Solé-Rodríguez

J. Gállego Pérez-Larraya

N. Huertas

J. Estela

M. Barón

N. Barbero-Bordallo

M. Encuentra

I. Dlouhy

J. Bruna

F. Graus

机构：

[1] Hospital Universitari de Bellvitge-ICO Duran i Reynals,Neuro

[2] IDIBELL,Oncology Unit

[3] L’Hospitalet de Llobregat,Department of Cell Biology, Physiology and Immunology, Institute of Neurosciences

[4] Universitat Autònoma de Barcelona,Department of Hematology

[5] and Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED),Department of Pathology

[6] Catalan Institute of Oncology-Hospital Duran i Reynals,Department of Neurology

[7] IDIBELL,Department of Neurology

[8] Universitat de Barcelona,Department of Neurology

[9] L’Hospitalet de Llobregat,Department of Hematology, Vall d’Hebron Institute of Oncology (VHIO)

[10] Unit of Neuro-Oncology. Hospital Universitari de Bellvitge-ICO Duran i Reynals,Department of Neurology

[11] IDIBELL,Department of Neurology

[12] L’Hospitalet del Llobregat,Department of Hematology

[13] Complejo Asistencial Universitario,Department of Neurology

[14] Hospital Universitario Son Espases,Department of Hematology

[15] Hospital Universitario y Politécnico La Fe,Department of Neurosurgery

[16] University Hospital Vall d’Hebron,Department of Hematology

[17] Hospital Universitario Miguel Servet,Department of Neurology

[18] Virgen de la Arrixaca University Hospital,Department of Hematology

[19] Hospital Universitario 12 de Octubre,Neurology Department

[20] Hospital Clínico Universitario de Santiago de Compostela,Department of Neurology

[21] Hospital Universitario Mutua de Terrassa,Department of Hematology

[22] Hospital Universitario Marqués de Valdecilla,Department of Hematology

[23] ICO-IJC-Hospital Germans Trias i Pujol,Department of Hematology

[24] Hospital Universitario Cruces,Departament of Neurology

[25] Hospital Clínico Universitario de Valladolid,Department of Neurology

[26] Complejo Hospitalario de Navarra,Department of Neurology

[27] Navarra Institute for Health Research (IdiSNA),Department of Neurology

[28] Hospital Universitario Quirónsalud Madrid,Department of Hematology and Neurology

[29] Hospital del Mar,Department of Neurology, Neuro

[30] Hospital de la Santa Creu i Sant Pau,Oncology Unit

[31] Hospital Universitario Virgen del Rocío,undefined

[32] Clínica Universidad de Navarra,undefined

[33] IdiSNA,undefined

[34] Instituto de Investigación Sanitaria de Navarra,undefined

[35] Hospital Universitario Severo Ochoa,undefined

[36] Hospital Parc Taulí,undefined

[37] Unit of Neurology,undefined

[38] Hospital Universitario Fundación Alcorcón,undefined

[39] Hospital Universitario Rey Juan Carlos,undefined

[40] HURJC-HUIE-HCV,undefined

[41] Hospital Clínic de Barcelona,undefined

[42] Hospital Universitari de Bellvitge and ICO L’Hospitalet,undefined

[43] C/Feixa Llarga S/N,undefined

来源：

Journal of Neuro-Oncology | 2020年 / 148卷

关键词：

Primary central nervous system lymphoma; Diagnostic delay; Steroids; Prognostic factors; Outcome;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：545 / 554

页数：9

共 51 条

[1]

Mendez JS(2018)The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades Neuro Oncol 20 687-694

[2]

Hoffman S(2006)Temporal trends in incidence of primary brain tumors in the United States, 1985–1999 Neuro Oncol 8 27-37

[3]

Propp JM(2017)Primary CNS lymphoma J Clin Oncol 35 2410-2418

[4]

McCarthy BJ(1999)Primary central nervous system lymphoma [editorial] J Neurol Neurosurg Psychiatry 66 699-701

[5]

Grommes C(2019)Radiotherapy or autologous stem-cell transplantation for primary CNS lymphoma in patients 60 years of age and younger: results of the intergroup ANOCEF-GOELAMS randomized phase II PRECIS study J Clin Oncol 37 823-833

[6]

DeAngelis LM(2015)First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)–a systematic review and individual patient data meta-analysis Ann Oncol 26 1305-1313

[7]

DeAngelis LM(1998)Long-term survival in primary CNS lymphoma J Clin Oncol 16 859-863

[8]

Houillier C(2005)Patterns of care for adults with newly diagnosed malignant glioma JAMA 293 557-564

[9]

Kasenda B(2019)Association of patterns of care, prognostic factors, and use of radiotherapy-temozolomide therapy with survival in patients with newly diagnosed glioblastoma: a French national population-based study J Neurooncol 142 91-101

[10]

Abrey LE(2020)Management and outcome of primary CNS lymphoma in the modern era: an LOC network study Neurology 94 e1027-e332

← 1 2 3 4 5 6 →